Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001640334-25-002331
Filing Date
2025-12-16
Accepted
2025-12-16 08:33:47
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 lxrp_424b5.htm 424B5 330771
2 lxrp_424b5img1.jpg GRAPHIC 3958
3 lxrp_424b5img2.jpg GRAPHIC 4787
4 lxrp_424b5img4.jpg GRAPHIC 3958
  Complete submission text file 0001640334-25-002331.txt   349826
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B5 | Act: 33 | File No.: 333-284407 | Film No.: 251573442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)